Abbott Laboratories (ABT) Stock Statistics & Valuation Metrics

Abbott Laboratories has a market cap or net worth of CHF124.44B. The enterprise value is CHF181.32B.

Abbott Laboratories has 1,741,812,400 shares outstanding. The number of shares has decreased by -2.65% in one year.

Abbott Laboratories’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 8.43%.

The current PE Ratio of Abbott Laboratories is 24.6. Abbott Laboratories’s PEG ratio is -0.65.

In the last 12 months, Abbott Laboratories had revenue of 44.33B and earned 6.52B in profits. Earnings per share was 3.74.

In the last 12 months, operating cash flow was 9.46B and capital expenditures -2.09B, giving a free cash flow of 7.38B billion.

Abbott Laboratories pays an annual dividend of CHF0.51, resulting in a dividend yield of 1.99%

Abbott Laboratories upcoming earnings date is Jul 16, 2026, Before Open (Confirmed).

Abbott Laboratories as a current ratio of 1.58, with Debt / Equity ratio of 65.40%

In the past 12 months, Abbott Laboratories has paid 1.94B in taxes.

Abbott Laboratories EV to EBITDA ratio is 19.51, with an EV/FCF ratio of 30.48.

Abbott Laboratories has CHF7.29B in cash and marketable securities with CHF34.05B in debt, giving a net cash position of -CHF26.75B billion.

Gross margin is 56.38%, with operating margin of 18.16%, and net profit margin of 14.72%.

The average price target for Abbott Laboratories is CHF95.37, which is 11.43% higher than the current price. The consensus rating is Strong Buy